An update on the role of miRNA-155 in pathogenic microbial infections

Microbes and Infection

Volumn 17, Issue 9, 2015, Pages 613-621

  Zeng, Fu Rong ^a   Tang, Li Jun ^a   He, Ye ^a   Garcia, R C ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Bacterial infection; Host cells; MiR 155; Viral infection

Indexed keywords

MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

APOPTOSIS; B LYMPHOCYTE; BACTERIAL INFECTION; BORNA DISEASE VIRUS; CANDIDA ALBICANS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; DENDRITIC CELL; DOWN REGULATION; HELICOBACTER PYLORI; HEPATITIS VIRUS; HERPESVIRIDAE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MACROPHAGE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA DEGRADATION; RNA TRANSLATION; T LYMPHOCYTE; ANIMAL; CELL LINE; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MOUSE; VIRUS INFECTION;

BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIAL INFECTIONS; CELL LINE; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICRORNAS; VIRUS DISEASES;

EID: 84940450699     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2015.05.007     Document Type: Short Survey

References (83)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001, 274:157-167.
5. Kluiver J., van den Berg A., de Jong D., Blokzijl T., Harms G., Bouwman E., et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007, 26:3769-3776.
6. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
7. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
8. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
9. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
10. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
11. Joseph T.T., Osman R. Thermodynamic basis of selectivity in guide-target-mismatched RNA interference. Proteins 2012, 80:1283-1298.
12. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
13. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
14. Schulte L.N., Westermann A.J., Vogel J. Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res 2013, 1:542-553.
15. Imaizumi T., Tanaka H., Tajima A., Yokono Y., Matsumiya T., Yoshida H., et al. IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am J Nephrol 2010, 32:462-468.
16. Billeter A.T., Hellmann J., Roberts H., Druen D., Gardner S.A., Sarojini H., et al. MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production. FASEB J 2014, 28:5322-5336.
17. George J., Lewis M.G., Renne R., Mattapallil J.J. Suppression of transforming growth factor β receptor 2 and Smad5 is associated with high levels of microRNA miR-155 in the oral mucosa during chronic simian immunodeficiency virus infection. J Virol 2015, 89:2972-2978.
18. Sonkoly E., Ståhle M., Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008, 18:131-140.
19. Tili E., Croce C.M., Michaille J.J. MiR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009, 28:264-284.
20. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. MiR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009, 1792:497-505.
21. Higgs G., Slack F. The multiple roles of microRNA-155 in oncogenesis. J Clin Bioinforma 2013, 3:17.
22. Zhang M., Zhou X., Wang B., Yung B.C., Lee L.J., Ghoshal K., et al. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Cont Release 2013, 168:251-261.
23. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Annu Rev Microbiol 2010, 64:123-141.
24. Bala S., Tilahun Y., Taha O., Alao H., Kodys K., Catalano D., et al. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 2012, 10:151.
25. Zhang Y., Wei W., Cheng N., Wang K., Li B., Jiang X., et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012, 56:1631-1640.
26. Sidorkiewicz M., Grek M., Jozwiak B., Majda-Stanislawska E., Piekarska A., Bartkowiak J. Expression of microRNA-155 precursor in peripheral blood mononuclear cells from hepatitis C patients after antiviral treatment. Acta Virol 2010, 54:75-78.
27. Jiang M., Broering R., Trippler M., Wu J., Zhang E., Zhang X., et al. MicroRNA-155 controls toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver. J Viral Hepat 2014, 21:99-110.
28. Riad S.E., EI-Ekiaby N., Mekky R.Y., Ahmed R., EI Din M.A., EI-Sayed M., et al. Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection. Biomed Rep 2015, 3:93-97.
29. El-Ekiaby N., Hamdi N., Negm M., Ahmed R., Zekri A.R., Esmat G., et al. Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4. FEBS Open Bio 2012, 2:179-186.
30. Cheng Y.Q., Ren J.P., Zhao J., Wang J.M., Zhou Y., Li G.Y., et al. MiR-155 regulates IFN-γ production in NK cells via Tim-3 signaling in chronic HCV infection. Immunology 2015, 10.1111/imm.12463.
31. Su C., Hou Z., Zhang C., Tian Z., Zhang J. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011, 8:354.
32. Verdonck K., González E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
33. Tomita M. Important roles of cellular microRNA miR-155 in leukemogenesis by human T-cell leukemia virus type 1 infection. ISRN Microbiol 2012, 2012:978607.
34. Wang L., Toomey N.L., Diaz L.A., Walker G., Ramos J.C., Barber G.N., et al. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. J Virol 2011, 85:8328-8337.
35. Maeda E., Akahane M., Kiryu S., Kato N., Yoshikawa T., Hayashi N., et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol 2009, 27:4-19.
36. Pfeffer S., Zavolan M., Grässer F.A., Chien M., Russo J.J., Ju J., et al. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
37. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappa B signaling and stabilizes latent virus persistence. J Virol 2008, 82:10436-10443.
38. Cameron J.E., Fewell C., Yin Q., McBride J., Wang X., Lin Z., et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008, 382:257-266.
39. Zhu X., Wang Y., Sun Y., Zheng J., Zhu D. MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration. Eur Arch Otorhinolaryngol 2014, 271:1939-1945.
40. Espinoza J.L., Takami A., Trung L.Q., Kato S., Nakao S. Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells. PLoS One 2012, 7:e51306.
41. Kim J.H., Kim W.S., Park C. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1. Leuk Lymphoma 2012, 53:1586-1591.
42. Dahlke C., Maul K., Christalla T., Walz N., Schult P., Stocking C., et al. A microRNA encoded by kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One 2012, 7:e49435.
43. Sin S.H., Kim Y.B., Dittmer D.P. Latency locus complements MicroRNA 155 deficiency in vivo. J Virol 2013, 87:11908-11911.
44. Zhao Y., Xu H., Yao Y., Smith L.P., Kgosana L., Green J., et al. Critical role of the virus-encoded MicroRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 2011, 7:e1001305.
45. Chi J.-Q., Teng M., Yu Z.-H., Xu H., Su J.-W., Zhao P., et al. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway. Virology 2015, 476:72-84.
46. Bhela S., Mulik S., Reddy P.B., Richardson R.L., Gimenez F., Rajasagi N.K., et al. Critical role of microRNA-155 in herpes simplex encephalitis. J Immunol 2014, 192:2734-2743.
47. Zawislak C.L., Beaulieu A.M., Loeb G.B., Karo J., Canner D., Bezman N.A., et al. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci U S A 2013, 110:6967-6972.
48. Swaminathan G., Rossi F., Sierra L.J., Gupta A., Navas-Martín S., Martín-García J. A role for microRNA-155 modulation in the anti-HIV-1 effects of toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012, 8:e1002937.
49. Bignami F., Pilotti E., Bertoncelli L., Ronzi P., Gulli M., Marmiroli N., et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood 2012, 119:6259-6267.
50. Seddiki N., Swaminathan S., Phetsouphanh C., Kelleher A.D. miR-155 is differentially expressed in treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients. Blood 2012, 119:6396-6397.
51. Martinez-Nunez R., Louafi F., Friedmann P.S., Sanchez-Elsner T. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)*. J Biol Chem 2009, 284:16334-16342.
52. Zhai A., Qian J., Kao W., Li A., Li Y., He J., et al. Borna disease virus encoded phosphoprotein inhibits host innate immunity by regulating miR-155. Antivir Res 2013, 98:66-75.
53. Pareek S., Roy S., Kumari B., Jain P., Banerjee A., Vrati S. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation 2014, 11:97.
54. Thounaojam M.C., Kundu K., Kaushik D.K., Swaroop S., Mahadevan A., Shankar S.K., et al. MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol 2014, 88:4798-4810.
55. Bolisetty M.T., Dy G., Tam W., Beemon K.L. Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol 2009, 83:12009-12017.
56. Choi E.J., Kim H.B., Baek Y.H., Kim E.H., Pascua P.N., Park S.J., et al. Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus. BMC Microbiol 2014, 14:252.
57. Wu Z., Hao R., Li P., Zhang X., Liu N., Qiu S., et al. MicroRNA expression profile of mouse lung infected with 2009 pandemic H1N1 influenza virus. PLoS One 2013, 8:e74190.
58. Eulalio A., Schulte L.N., Vogel J. The mammalian microRNA response to bacterial infections. RNA Biol 2012, 9:742-750.
59. Staedel C., Darfeuille F. MicroRNAs and bacterial infection. Cell Microbiol 2013, 15:1496-1507.
60. He Y., Li W., Liao G., Xie J. Mycobacterium tuberculosis-specific phagosome proteome and underlying signaling pathways. J Proteome Res 2012, 11:2635-2643.
61. Lee B.Y., Jethwaney D., Schilling B., Clemens D.L., Gibson B.W., Horwitz M.A. The Mycobacterium bovis bacille Calmette-Guérin phagosome proteome. Mol Cell Proteomics 2010, 9:32-53.
62. Yang S., Li F., Jia S., Zhang K., Jiang W., Shang Y., et al. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes apoptosis of macrophages via targeting the microRNA155-SOCS1 interaction. Cell Physiol Biochem 2015, 35:1276-1288.
63. Wu J., Lu C., Diao N., Zhang S., Wang S., Wang F., et al. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum Immunol 2012, 73:31-37.
64. Kumar R., Halder P., Sahu S.K., Kumar M., Kumari M., Jana K., et al. Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with Mycobacterium tuberculosis. Cell Microbiol 2012, 14:1620-1631.
65. Wang J., Wu M., Wen J., Yang K., Li M., Zhan X., et al. MicroRNA-155 induction by Mycobacterium bovis BCG enhances ROS production through targeting SHIP1. Mol Immunol 2014, 6:29-36.
66. Wang J., Yang K., Zhou L., Wu M.H., Wu Y., Zhu M., et al. MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog 2013, 9:e1003697.
67. Ghorpade D.S., Leyland R., Kurowska-Stolarska M., Patil S.A., Balaji K.N. MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages. Mol Cell Biol 2012, 32:2239-2253.
68. Xiao B., Liu Z., Li B.S., Tang B., Li W., Guo G., et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009, 200:916-925.
69. Tang B., Xiao B., Liu Z., Li N., Zhu E.D., Li B.S., et al. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 2010, 584:1481-1486.
70. Koch M., Mollenkopf H.J., Klemm U., Meyer T.F. Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci U S A 2012, 109:E1153-E1162.
71. Saito Y., Suzuki H., Tsugawa H., Imaeda H., Matsuzaki J., Hirata K., et al. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 2012, 7:e47396.
72. Fassi Fehri L., Koch M., Belogolova E., Khalil H., Bolz C., Kalali B., et al. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One 2010, 5:e9500.
73. Schnitger A.K., Machova A., Mueller R.U., Androulidaki A., Schermer B., Pasparakis M., et al. Listeria monocytogenes infection in macrophages induces vacuolar-dependent host miRNA response. PLoS One 2011, 6:e27435.
74. zar B., Mannala G.K., Mraheil M.A., Chakraborty T., Hain T. MicroRNA response to Listeria monocytogenes infection in epithelial Cells. Int J Mol Sci 2012, 13:1173-1185.
75. Lind E.F., Elford A.R., Ohashi P.S. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol 2013, 190:1210-1216.
76. Giahi L., Aumueller E., Elmadfa I., Haslberger A.G. Regulation of TLR4, p38 MAPkinase, IkappaB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Benef Microbes 2012, 3:91-98.
77. Sharbati S., Sharbati J., Hoeke L., Bohmer M., Einspanier R. Quantification and accurate normalisation of small RNAs through new custom RT-qPCR arrays demonstrates Salmonella-induced microRNAs in human monocytes. BMC Genomics 2012, 13:23.
78. Schulte L.N., Eulalio A., Mollenkopf H.J., Reinhardt R., Vogel J. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. EMBO J 2011, 30:1977-1989.
79. Dilda F., Gioia G., Pisani L., Restelli L., Lecchi C., Albonico F., et al. Escherichia coli lipopolysaccharides and Staphylococcus aureus enterotoxin B differentially modulate inflammatory microRNAs in bovine monocytes. Vet J 2012, 192:514-516.
80. Rao R., Rieder S.A., Nagarkatti P., Nagarkatti M. Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury. Infect Immun 2014, 82:2971-2979.
81. Clare S., John V., Walker A.W., Hill J.L., Abreu-Goodger C., Hale C., et al. Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice. Infect Immun 2013, 81:723-732.
82. Cremer T.J., Fatehchand K., Shah P., Gillette D., Patel H., Marsh R.L., et al. MiR-155 induction by microbes/microbial ligands requires NF-kappaB-dependent de novo protein synthesis. Front Cell Infect Microbiol 2012, 2:73.
83. Monk C.E., Hutvagner G., Arthur J.S.C. Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One 2010, 5(10):e13669. 10.1371/journal.pone.0013669.